CClinicalTrials.gg
CompletedNCT03759119Updated Mar 24, 2020

Use of a Tummy Time Intervention and Parent Education in Infants Born Preterm

An interventional study of Tummy time and parent education and Parent education only in Premature Birth, sponsored by University of Indianapolis. Completed at 1 site in United States. Open to participants aged 35 Weeks to 44 Weeks. Per ClinicalTrials.gov, last updated 2020-03-24.

Sponsored by University of Indianapolis · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
26
Allocation
Randomized
Ages
35 Weeks to 44 Weeks
Sex
All
01

Study summary

The purpose of this research study is to see if tummy time and parent education helps motor development among infants born preterm. Participants will be recruited from Ann and Robert H. Lurie Children's Hospital of Chicago neonatal intensive care unit.

Read the detailed description

The purpose of this randomized control trial will be to investigate the effects of a tummy time intervention, as compared to standard care, on motor outcomes among premature infants over a four-week period. Additionally, the study will measure tummy time adherence rates between groups post intervention for an additional four weeks.

To meet this purpose, the following objectives will be addressed:

  1. To determine if there will be a difference in motor outcome scores on the Test of Infant Motor Performance (TIMP) among infants born preterm and utilizing a tummy time intervention and parent education compared to those in the standard care group receiving parent education only.
  2. To determine if there will be a difference in adherence rates (average minutes/day) between groups among infants born preterm utilizing a tummy time intervention and parent education compared to those in the standard care group receiving parent education only.
02

Conditions studied

  • Premature Birth

Browse trials for

03

Who can participate

Ages eligible
35 Weeks to 44 Weeks
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

To be eligible to participate in the study, participants must meet the following inclusion criteria:

  • born premature (\< 37 weeks' gestation),
  • require medical care within Lurie Children's NICU, be between 35 and 44 weeks postmenstrual age.
  • Primary parent must have a working mobile device.
  • Participants must be English or Spanish speaking as primary language.

Exclusion criteria

Exclusion criteria:

  • primary parent does not having a working mobile device and
  • Speaking a language other than English or Spanish.
  • Unable to be placed in the prone position,
  • Physiologically unstable for handling
  • Orally intubated or have a tracheostomy
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
26 participants (actual)

Study arms

  • Experimental
    Tummy Time and Parent Education

    This group will receive tummy time and parent education and be encouraged to perform tummy time on their own. They will utilize the PT Pal application to record their tummy time adherence. The primary investigator performs the intervention to the participants two times a day for 10 minutes for 4 weeks.

    Behavioral: Tummy time and parent education · Behavioral: Parent education only

  • No intervention
    Parent education

    This group will receive parent education only and utilize the PT Pal application to record their adherence. The primary caregiver will be encouraged to perform the same dosage of tummy time (2x/day, 10 minutes each, 4 weeks) and record their adherence on the PT Pal application.

Interventions

  • BehavioralTummy time and parent education

    Participants will receive tummy time positioning while awake for 10 minutes two times a day. Physiological monitoring will be maintained throughout the entire intervention and the intervention will be adjusted if needed to maintain stability. Participants will also receive parent education on tummy time prior to the tummy time intervention. The primary investigator will perform the tummy time intervention. Participants will be encouraged to continue performing tummy time on their own and record their adherence via the PT Pal application.

    Also known as: Group 1

  • BehavioralParent education only

    Participants will receive the same tummy time education as those in the intervention group and will be asked to continue the intervention on their own and record their adherence via the PT Pal application. Steps of the intervention for group 2 (standard care). * Complete educational session with primary investigator. * Adherence during the four-week intervention period will be measured remotely through the PT Pal® application.

    Also known as: Group 2

05

What researchers measure

Primary outcomes

  1. Test of Infant Motor Performance (TIMP) for motor outcome

    The TIMP is a functional motor scale for newborns, including those born premature, up to infants four months corrected age, and was specifically designed for use in neonatal intensive care units (Rose \& Westcott, 2005).

    Time frame: Change in motor outcome will be measured at initiation and at 8 weeks. Each participant will be enrolled in the study for 8 weeks. The study is expected to be completed within 6 months.

Secondary outcomes

  1. PT Pal Application: Adherence

    The PT Pal application will be utilized to generate information back to the PI on adherence with tummy time outcomes of the prescription recommendations and thus serves as an adherence component for both the intervention and the standard care group.

    Time frame: Change in adherence will be measured at initiation and at 8 weeks. Each participant will be enrolled in the study for 8 weeks. The study is expected to be completed within 6 months.

06

Study locations

1 site
  • Ann and Robert H. Lurie Children's Hospital of Chicago
    Chicago, Illinois 60611, United States
07

References and documents

Publications

  • Bentzley JP, Coker-Bolt P, Moreau NG, Hope K, Ramakrishnan V, Brown T, Mulvihill D, Jenkins D. Kinematic measurement of 12-week head control correlates with 12-month neurodevelopment in preterm infants. Early Hum Dev. 2015 Feb;91(2):159-64. doi: 10.1016/j.earlhumdev.2015.01.001. Epub 2015 Jan 23. PubMed 25621433 ↗
  • Campbell SK, Hedeker D. Validity of the Test of Infant Motor Performance for discriminating among infants with varying risk for poor motor outcome. J Pediatr. 2001 Oct;139(4):546-51. doi: 10.1067/mpd.2001.117581. PubMed 11598602 ↗
  • Lekskulchai R, Cole J. Effect of a developmental program on motor performance in infants born preterm. Aust J Physiother. 2001;47(3):169-76. doi: 10.1016/s0004-9514(14)60264-6. PubMed 11552873 ↗
  • Oberg GK, Campbell SK, Girolami GL, Ustad T, Jorgensen L, Kaaresen PI. Study protocol: an early intervention program to improve motor outcome in preterm infants: a randomized controlled trial and a qualitative study of physiotherapy performance and parental experiences. BMC Pediatr. 2012 Feb 15;12:15. doi: 10.1186/1471-2431-12-15. PubMed 22336194 ↗
08

Registry details

Key details

Study ID
NCT03759119
Lead sponsor
University of Indianapolis
Collaborators
Ann & Robert H Lurie Children's Hospital of Chicago
Responsible party
Kathryn Martin (Dawn Drumm, PT Physical Therapist, University of Indianapolis) — Principal investigator
First posted
Nov 29, 2018
Start date
Feb 6, 2019
Primary completion
Mar 23, 2020
Completion
Mar 23, 2020
Last update
Mar 24, 2020

Study contacts

Kathy Martin, DHSc
study chair · University of Indianapolis

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion